Clinical trial

Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection

NCT00150891 · University of Giessen, Other · Completed

Key facts

NCT number NCT00150891
Title Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
Official title Role of Th1, Th2 and Monokine Responses as Risk Factors of Acute and Chronic Renal Transplant Rejection - Impact of Different Immunosuppressive Protocols
Lead sponsor University of Giessen, Other
Collaborators Heidelberg University Astellas Pharma Inc Industry Novartis Fresenius AG Hoffmann-La Roche Biotest
Status Completed
Study type Observational
Conditions Renal Failure, Chronic
Intervention type Drug, Procedure
Interventions Kidney transplantation, cyclosporine A, tacrolimus, azathioprine, mycophenolate mofetil
Enrollment 84
Start date Jan 1, 1998
Completion Jan 1, 2006
First posted Sep 8, 2005
Last update posted May 10, 2007
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies